Achieve Life Sciences Announces Successful Completion of the Second and Final DSMC Review of Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation
Stock Information for Achieve Life Sciences Inc.
Loading
Please wait while we load your information from QuoteMedia.